Mucosolvan Kindersaft (Ambroxol Hydrochloride)

Ambroxol hydrochloride works by stimulating the production of surfactant in the respiratory tract and by breaking down the molecular bonds that make mucus thick. This reduces mucus viscosity, enhances mucociliary transport, and facilitates the expectoration of secretions, thereby easing airway obstruction.

The appropriate dose of Mucosolvan Kindersaft is determined by the prescribing healthcare professional based on the child’s age, weight, and clinical condition. Dosage instructions are provided on the product label and should be followed exactly as directed by the prescriber.

Safety data for ambroxol hydrochloride in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should be consulted before use in these situations.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details and any necessary import documentation.

Ambroxol, the active ingredient in Mucosolvan Kindersaft, is a well‑studied mucolytic that not only thins mucus but also stimulates surfactant production, offering a dual mechanism. Compared with agents such as N‑acetylcysteine, ambroxol may have a more favorable taste profile for children and a lower incidence of bronchospasm.

Store Mucosolvan Kindersaft at ambient temperature, preferably below 25 °C. Keep the bottle in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain product stability.

Mucosolvan Kindersaft is administered orally using the supplied measuring device. The dose is given directly into the mouth, preferably after a meal to reduce gastrointestinal discomfort. Care should be taken to measure the exact volume prescribed by the healthcare professional.

Serious adverse reactions, although rare, include allergic responses such as urticaria, angioedema, or anaphylaxis, as well as severe skin conditions like Stevens‑Johnson syndrome. Hepatic dysfunction and blood dyscrasias such as eosinophilia or neutropenia have also been reported and require prompt medical attention.

Mucosolvan Kindersaft should not be used by individuals with a known hypersensitivity to ambroxol hydrochloride or any of the formulation excipients. It is also contraindicated in patients who have experienced severe allergic reactions to other mucolytic agents.